3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
25
Stomach Neoplasms
11
Pancreatic Neoplasms
11
Colonic Neoplasms
9
Rectal Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Esophageal Neoplasms
6
Adenocarcinoma Of Esophagus
6
Neoplasms
5
Cholangiocarcinoma
5
Burkitt Lymphoma
5
Neoplasm Metastasis
4
Carcinoma, Non-Small-Cell Lung
4
Urinary Bladder Neoplasms
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Ovarian Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Lung Neoplasms
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Urethral Neoplasms
1
Urachal cancer
1
Unresectable Colorectal Cancer
1
Triple Negative Breast Neoplasms
1
Interventions
Oxaliplatin
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Locally Advanced Pancreatic Cancer
×
Leucovorin
×
Clear all
NCT05466799
2026-02-13
TRIPP-FFX
OncoSil Medical Limited
Phase 2
Active not recruiting
88 enrolled